New York, USA, May 11, 2022 (GLOBE NEWSWIRE) — Research Dive says the global computer-aided drug discovery market should bring in an income of $7,914.2 million by 2028 and growing at a CAGR of 15.0% in the forecast period from 2021 to 2028. The global Computer Aided Drug Discovery market report provides a brief summary of the current market scenario along with key aspects of the industry such as growth factors and restrictions, challenges and multiple opportunities for growth. In addition, the report provides all market estimates, which helps new participants to better understand the global market.

Market dynamics

Research Dive analysts say the increasing use of artificial intelligence (AI) and machine learning (ML) in drug discovery for polypharmacology, chemical synthesis and drug screening to study 3D structure molecules are the major factors promoting the growth of the global computer-aided drug discovery market over the analysis period. Furthermore, growing demand for drug development for various diseases such as cardiovascular disease, cancer, and others is another factor that is expected to drive the market growth. Additionally, the advancements in computer-aided drug discovery (CADD) and the use of AI technology in the integration of CADD are expected to create huge opportunities for the growth of the global market by 2028. However, lack of skilled technicians and technical knowledge in CADD are factors that are expected to limit the market growth in the estimated time frame.

Download Sample PDF of the Computer-Aided Drug Discovery Market @ https://www.researchdive.com/download-sample/159

Impact of COVID-19 on the industry

The COVID-19 outbreak has positively impacted the global computer-aided drug discovery market during the pandemic. The increase in the growth rate of the market is mainly attributed to the growth in R&D activities among biotech and biopharmaceutical companies, researchers and scientists to develop an effective drug or treatment against COVID-19. Thus, the importance of drug research and discovery increases in times of pandemic, which drives the growth of the market.

The structure-based drug design sub-segment will witness significant growth

By type, the structure-based drug design sub-segment of the global computer-aided drug discovery market is expected to grow at the fastest rate and generate a revenue of $2,539.4 million. during the forecast period. Technological advancements coupled with the growing demand for new drugs for several diseases are increasing the demand for structure-based CADD-like drug design.

Cardiovascular disease sub-segment to witness lucrative growth

Based on therapeutic area, the cardiovascular disease sub-segment of the global computer-aided drug discovery market accounted for $454.1 million in 2020 and is expected to grow at the fastest rate during the forecast period. This considerable growth in the market can be mainly due to the increasing prevalence of heart diseases in the world. Furthermore, increasing importance of surveillance work and obtaining data during the development of cardiovascular disease drugs is another factor expected to boost the growth of the sub-segment by 2028.

Click here! To get in touch with our expert analyst to learn more about the growth of the computer-aided drug discovery market @ https://www.researchdive.com/connect-to-analyst/159

The North America region will dominate in the industry

According to region, the North American computer-aided drug discovery market was worth $991.7 million in 2020 and is expected to dominate the global industry throughout the forecast period. The strong growth of the regional market is mainly due to the increase in advanced research activities in the field of cancer using CADD in various institutes and hospitals. For example, Ohio State University was the first academic medical center in the United States to use a new computer-assisted system for colonoscopy screening of patients undergoing tests or treatment in the hospital.

Main market players

The report presents several aspects of these major players such as strategic moves and business and financial performance of key players, latest developments, SWOT analysis and product portfolio. Some of the key players in the global computer-aided drug discovery market are:

• Albany Molecular Research Inc. (AMRI)
• BOCSCI inc.
• Astra Zeneca
• Bioduro Sundia
• Schrodinger, Inc.
• Bayer AG
• Aragen Life Sciences Pvt. ltd.
• Charles River Laboratories
• Aris Pharmaceuticals.

These players are executing several strategies to gain a dominant position in the global industry.

For example, in November 2020, Schrödinger, Inc., the science leader involved in the development of cutting-edge chemical simulation software for use in pharmaceutical, materials and biotechnology research, and Bristol Myers Squibb, a multinational pharmaceutical company, has entered into a research collaboration to discover, develop and commercialize therapies for various diseases.

Request On-Demand Customization of Computer-Aided Drug Discovery Market Research Report and Get 10% Off @ https://www.researchdive.com/request-for-customization/159

Some trending article links: